Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Competitive repopulation in leukemic and normal bone marrow

G Brecher1, M G Pallavicini, E P Cronkite

  • 1Cell and Molecular Biology Division, Lawrence Berkeley Laboratory, Berkeley, CA 94720.

Blood Cells
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamics of hemopoietic proliferation in man and mice studied by H3-thymidine incorporation into DNA.

Progress in nuclear energy. Series 6 Biological sciences·2014
Same author

Injuries produced by the atomic bomb; observations on animals exposed at Bikini.

The American journal of pathology·2010
Same author

The hematology of the Bikini animals.

The American journal of pathology·2010
Same author

Telomerase activity in mouse myeloid leukemic cells and in cells from normal hematopoietic systems.

Blood cells, molecules & diseases·2001
Same author

Characterization of genetic instability in radiation- and benzene-induced murine acute leukemia.

Mutation research·1999
Same author

Advantages of the CBA mouse in leukemogenesis research.

Blood cells, molecules & diseases·1999
Same journal

In vitro and in vivo studies of stromal niches.

Blood cells·1994
Same journal

Differential manipulation of normal and chronic myeloid leukemia stem cell proliferation in vitro.

Blood cells·1994
Same journal

Enrichment for primitive hemopoietic progenitors of marrow cells from 5-fluorouracil-treated mice and normal mice.

Blood cells·1994
Same journal

Protein tyrosine phosphorylation in the regulation of hematopoiesis by receptors of the cytokine-receptor superfamily.

Blood cells·1994
Same journal

Lysis of blood platelets by human osteosarcoma cells in vitro.

Blood cells·1994
Same journal

Development of hemopoietic bone marrow within the ectopic bone induced by bone morphogenetic protein.

Blood cells·1994
See all related articles

Chemotherapy success in leukemia suggests normal stem cells persist. Stimulating these normal cells with cytokines may help them outcompete remaining leukemia cells, potentially avoiding complete eradication.

Area of Science:

  • Hematology
  • Cancer Biology
  • Stem Cell Biology

Background:

  • Chemotherapy for leukemia, even with extensive marrow infiltration, implies residual normal stem cells.
  • The dynamics of normal and leukemic stem cell competition mirror donor-host interactions in irradiated animals.
  • Quantitative relationships between competing stem cells are crucial, even with proliferative advantages.

Purpose of the Study:

  • To explore the therapeutic potential of stimulating surviving normal stem cells in leukemia.
  • To investigate if normal stem cells can regain dominance over residual leukemic cells.
  • To suggest novel therapeutic strategies based on stem cell competition dynamics.

Main Methods:

  • Review of stem cell competition in irradiated animals.

Related Experiment Videos

  • Analogical reasoning applied to leukemia stem cell dynamics.
  • Hypothetical therapeutic strategy involving cytokine stimulation.

    • Main Results:

    • The success of chemotherapy indicates the persistence of normal hematopoietic stem cells.
    • Stem cell competition is influenced by quantitative relationships and proliferative advantages.
    • Cytokine-mediated stimulation of normal stem cells is proposed as a therapeutic avenue.

    Conclusions:

    • Complete eradication of leukemic cells may not be essential for successful treatment.
    • Enhancing the competitive ability of surviving normal stem cells could be a viable therapeutic goal.
    • Leveraging cytokine combinations to promote normal stem cell recovery offers a promising strategy in leukemia treatment.